Article
Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review.
PloS one - 1 Jan 2013
Morgan Jessie A, Bombell Sarah, McGuire William
Abstract excerpt
BACKGROUND AND AIMS: Excessive generation of plasminogen activator inhibitor-type 1 (PAI-1) is implicated in the pathogenesis of pre-eclampsia and related conditions. The PAI-1 (-675 4G/5G) promoter polymorphism (rs1799889) affects transcriptional activity and is a putative genetic risk factor for pre-eclampsia. The aim of this study was identify, appraise and synthesise the available evidence for the association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
